v3.25.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of worldwide net revenues
The following table details AbbVie’s worldwide net revenues:
Three months ended
March 31,
(in millions)20252024
Immunology
SkyriziUnited States$2,919 $1,656 
International506 352 
Total$3,425 $2,008 
RinvoqUnited States$1,220 $725 
International498 368 
Total$1,718 $1,093 
HumiraUnited States$744 $1,771 
International377 499 
Total$1,121 $2,270 
Neuroscience
VraylarUnited States$763 $692 
International2 2 
Total$765 $694 
Botox TherapeuticUnited States$723 $611 
International143 137 
Total$866 $748 
UbrelvyUnited States$233 $197 
International7 6 
Total$240 $203 
QuliptaUnited States$172 $128 
International21 3 
Total$193 $131 
VyalevUnited States$6 $— 
International57 9 
Total$63 $9 
DuodopaUnited States$20 $25 
International76 90 
Total$96 $115 
Other NeuroscienceUnited States$55 $61 
International4 4 
Total$59 $65 
Three months ended
March 31,
(in millions)20252024
Oncology
ImbruvicaUnited States$529 $610 
Collaboration revenues209 228 
Total$738 $838 
VenclextaUnited States$312 $281 
International353 333 
Total$665 $614 
Elahere
United States
$165 $64 
International
14 — 
Total$179 $64 
Epkinly
Collaboration revenues
$36 $22 
International15 5 
Total$51 $27 
Aesthetics
Botox CosmeticUnited States$295 $389 
International261 244 
Total$556 $633 
Juvederm CollectionUnited States$75 $106 
International156 191 
Total$231 $297 
Other AestheticsUnited States$270 $281 
International45 38 
Total$315 $319 
Eye Care
OzurdexUnited States$30 $34 
International93 97 
Total$123 $131 
Lumigan/GanfortUnited States$48 $29 
International58 62 
Total$106 $91 
Alphagan/CombiganUnited States$26 $15 
International34 44 
Total$60 $59 
Other Eye CareUnited States$117 $149 
International100 108 
Total$217 $257 
Other Key Products
MavyretUnited States$142 $144 
International164 205 
Total$306 $349 
CreonUnited States$355 $285 
Linzess/ConstellaUnited States$139 $257 
International9 9 
Total$148 $266 
All other$747 $744 
Total net revenues$13,343 $12,310